◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Godrej Consumer Products Limited (GODREJCP) Revenue 2022–TTM

Name: Godrej Consumer Products Limited (GODREJCP) revenue history 2022-TTM
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-11-02

Godrej Consumer Products Limited annual revenue for fiscal TTM was ₹165.7 billion, an increase of 9.7% from ₹151.0 billion in fiscal 2026. All figures are reported results from public filings — no estimates or projections.

GODREJCP Annual Revenue

Revenue (annual)	TTM → 2026-09-30	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	₹165.7B	₹151.0B	₹139.2B	₹139.7B	₹132.0B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

GODREJCP Quarterly Revenue

Revenue (quarterly)	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Total Revenue	₹44.0B	₹42.1B	₹38.8B	₹40.8B	₹36.9B	—	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Revenue at Comparable Companies

4452 Revenue — Kao Corporation
8113 Revenue — Unicharm Corporation
4911 Revenue — Shiseido Company, Limited
MARICO Revenue — Marico Limited
DABUR Revenue — Dabur India Limited
4527 Revenue — Rohto Pharmaceutical Co.,Ltd.

More GODREJCP metrics: Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow

All GODREJCP financial statements → Interactive GODREJCP charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.